DMT1 (NRAMP2/DCT1) genetic variability and resistance to recombinant human erythropoietin therapy in chronic kidney disease patients under haemodialysis

Acta Haematol. 2008;120(1):11-3. doi: 10.1159/000149496. Epub 2008 Aug 1.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Alleles
  • Anemia, Iron-Deficiency / drug therapy
  • Anemia, Iron-Deficiency / etiology
  • Anemia, Iron-Deficiency / genetics
  • Case-Control Studies
  • Cation Transport Proteins / genetics*
  • Drug Resistance / genetics
  • Erythropoietin / therapeutic use*
  • Female
  • Gene Frequency
  • Genetic Variation
  • Haplotypes
  • Humans
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / genetics*
  • Kidney Failure, Chronic / therapy*
  • Male
  • Middle Aged
  • Point Mutation
  • Polymorphism, Single Nucleotide
  • Recombinant Proteins
  • Renal Dialysis

Substances

  • Cation Transport Proteins
  • Recombinant Proteins
  • solute carrier family 11- (proton-coupled divalent metal ion transporters), member 2
  • Erythropoietin